Venture capitalists across the country invested more — in dollars and frequency — in software and biotechnology companies during the second quarter of 2013 when compared to the prior quarter, a new report shows. The national trend, reported in Friday’s The MoneyTree™ Report by PricewaterhouseCoopers and the National Venture Capital Association (NVCA) based on data from Thomson Reuters, holds true locally, too.
To read the full, original article click on this link: Venture capitalists invest more in software, biotech startups - St. Louis Business Journal
